FOLR2 and prostate carcinoma: Limitations include the retrospective design and the inability to distinguish FR-β expression from immune cell infiltration.<h4>Conclusions</h4>Our large-scale study of transcriptome demonstrates FOLR2 gene expression is associated with aggressive prostate cancer in samples with low expression of PSMA.